Active immunization with the idiotype of follicular lymphoma induces tumor-specific immunity.
Introduction
The individual composition of potentially immunogenic epitopes of any immunoglobulin is designated as "idiotype". The idiotype is a unique feature for every B-cell clone and a tumorspecific antigen in B-cell lymphoma. Immunization of patients with follicular lymphoma (FL) against their lymphoma idiotype induces tumor-specific immunity. [1] [2] [3] When idiotype vaccination is administered as remission consolidation after conventional chemotherapy, humoral immune responses correlate with superior outcome. [4] [5] [6] Idiotype-specific, MHC class I-restricted cytotoxic T cells circulate in lymphoma-bearing patients. 7 Immunization with recombinant idiotype F ab fragments induces idiotype-directed T cells in the majority of patients. 8, 9 In the first trial testing idiotype vaccination as upfront intervention without prior cytoreductive therapy, anti-idiotype T-cell responses correlated with superior progression-free survival and with durable lymphoma remissions. 9 Peptide mapping experiments revealed that these T-cell responses are consistently directed against HLA class I-restricted peptides from the complementarity-determining regions (CDR) or against hypermutated idiotype epitopes. 8, 9 These findings are in accordance with animal studies demonstrating T cells tolerance for germline-encoded immunoglobulin sequences but responsiveness to novel idiotopes arising from junctional diversity or somatic mutations. 10 Since mouse models have also shown T cell-mediated immunosurveillance against hypervariable idiotypic peptides, 11 we sought to obtain evidence that spontaneous idiotypedirected T-cell immunity is operational in non-immunized lymphoma patients and impairs expansion of malignant B cell clones that express an idiotype with high immunogenicity. To test this hypothesis, we performed a "reverse immunology" bioinformatics study in 39 FL patients.
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Methods

Patients
The study was approved by the institutional ethics committee of University Medical Center Freiburg. All patients provided informed consent for biopsies and immunological studies in accordance with the Declaration of Helsinki. HLA types were identified by serotyping and high-resolution genotyping (Olerup SSP kit, Qiagen, Hilden, Germany).
Analyses of idiotype sequences
Immunoglobulin heavy and light chain cDNAs from FL biopsies were cloned by A-PCR and sequenced. 12 Identification of variable regions, mutational status, and assignment to CDR and framework regions (FR) were performed by the IMGT/V-QUEST algorithm (imgt.cines.fr). Peptides predicted to bind to HLA-A and -B alleles were identified by the BIMAS algorithm (www-bimas.cit.nih.gov/molbio/hla_bind/). The sum of the binding scores of the 20 highest ranking peptides served as a measure for the theoretical idiotype HLA binding capacity and was calculated for all idiotypes and all 39 HLA types. For every patient's HLA type, the idiotype sum scores of his/her lymphoma ("autologous" score) was compared to the mean of the sum scores on the remaining 38 idiotypes ("allogeneic" scores) in a matchedpair analysis with Wilcoxon's signed rank test (Prism 5.02; GraphPad Software, San Diego, CA). For region-specific analyses, peptides containing at least two amino acids assigned to a CDR were defined as CDR epitopes, the remaining as FR peptides.
Results and Discussion
The V H usage ( Supplemental Table) did not differ significantly from reported series. 13 Except for an overrepresentation of the rare allele HLA-A68 (p<0.01; two-sided Χ 2 test with Bonferroni's adjustment), the HLA allele distribution was representative for the German population. 14, 15 A median of three (range: 1-4) HLA alleles per patient could be analyzed in BIMAS. The median score of the highest-ranking peptide of each idiotype was 69.6 (range: 4 -2000) .
Scores >320 occurred exclusively for HLA-B2705 (2 patients). Median scores for peptides with rank 15 and 20 were 2.0 and 1.1, respectively. Therefore, calculation of sum scores from the 20 highest ranking peptides reliably included all relevant epitopes. Most of these bona fide peptides are expected to physically bind to HLA and to serve as functional T-cell epitopes. 8, 9, [16] [17] [18] In a matched-pair comparison of the idiotype BIMAS sum scores, the V H region of an affected patient's own lymphoma had lower HLA binding scores than allogeneic idiotypes ( Figure 1 ). No such global difference was observed for idiotype V L regions.
Additional analyses were performed to assign differential idiotype immunogenicity to FR and CDR. Since immunogenicity of HLA-presented peptides may depend on a single non-anchor residue, we considered peptides as CDR-derived if at least two amino acids were assigned to a CDR. With this definition, the cumulative sequence length that could harbour CDR or FR epitopes was relatively balanced (V H : FR 56%, CDR 44%; V L : FR 58%, CDR 42%). As described before, 18 the majority of peptides with high HLA binding scores were located in FR: only 35% and 25% of all peptides with scores >10 and >50, respectively, were CDR-derived.
Despite higher FR sum scores, weaker HLA binding of autologous idiotypes was dependent on hypervariable sequences, and each CDR contributed significantly to this difference ( Figure 1 ). The same phenomenon was observed for V L CDR. Regarding FR, a highly significant difference between autologous and allogeneic sequences was found only for V H FR2. Animal studies have demonstrated immunosurveillance against MHC class II-restricted idiotype epitopes. 10, 11 The available in silico tools permit only limited analyses for human MHC class II. Therefore, our study had to focus on HLA class I. The results indicate natural selection against FL idiotypes with relatively high HLA binding capacity by T cell-mediated immunosurveillance.
Hypermutated FL idiotypes and corresponding germ-line V H and V L segments had similar HLA binding sum scores (Fig. 2) . We cannot ascertain absolute identity of the germ-line sequences deposited in the IMGT database with the individual patients' V genes. Despite this caveat, the dominant influence of the hypervariable regions on differential HLA binding scores was apparently unaltered by somatic hypermutation, a process constitutively activated in FL. 19, 20 Therefore, immunosurveillance appears to take effect in suppressing FL cells with idiotypes that acquire increased immunogenicity by random mutations.
If the immune system suppresses FL cells expressing idiotypes with relatively high
immunogenicity, the idiotype of a clinically manifest lymphoma is apparently ignored. Cells carrying the FL-associated t(14;18) circulate in healthy individuals over extended time periods. 21, 22 Our results permit to speculate that idiotype-specific T cells contribute to prevent malignant outgrowth of these B-cell clones.
Immunosurveillance of idiotypes appears to be predominantly dependent on individual, CDRderived epitopes despite their weaker predicted HLA binding compared to FR peptides.
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